So here we are waiting for October's revenue annou

So here we are waiting for October's revenue announcement and the Q3 10K. I expect Mr. Schneiderman will release October's number very soon, we'll see. My expectations are if we maintain a $5M+ number we are doing very, very well. Eight months ago when I did my own DD on compounding pharmacies I was told a compounding pharmacy generating $5M monthly is considered a healthy pharmacy. We reached that number in just seven months. We read about Jungle Jim and the TN Apothecary being folded into the ScripsAmerica portfolio but to date we haven't heard any news on their impact. We also read these two negotiated deals involve several other pharmacies in other States. All this takes time. I wouldn't be surprised if it takes another 60 to 90 days before JJ and TN Apothecary are fully integrated. Until we learn these two deals are fully integrated, that is contributing to SCRC's revenues, I would be excited to see MAP come in each month around the $5M number. Let's face it, one pharmacy can only generate a revenue number equal to the number of staff available to fill the Rxs. After Jungle Jim and TN Apothecary are fully integrated there is no reason why ScripsAmerica couldn't top the $6M number or higher on a monthly basis. Having been in the pharma industry for over 37 years I know third party payers will eventually impact the revenues but to date this has not happened. If I'm not mistaken, we were supposed to see this negative impact in September but as you know September's number was once again record breaking. Right now at $5M SCRC is looking at a $60M annual run rate. We know Mr. Schneiderman is scheduled to present the SCRC success story at the See TruEquity Investors Conference in New York City on November 12th. It will be exciting to hear what type of news he presents at this conference. I don't know how anyone can argue the present and future success of SCRC. Being an SCRC investor for almost two years now, I believe the best is yet to come.